Clinical Trials on Dermatologic Conditions

Total 436298 results

Jazz Pharmaceuticals

Completed

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

Hematologic Neoplasms

United States
Pharmacyclics LLC.

Completed

Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients

Neoplasms | Hematologic Neoplasms

United States
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University; Université Paris XII

Completed

Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion (ILD-Treg)

Hematologic Neoplasms | Relapse

France
University College, London
bluebird bio

Active, not recruiting

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant (ITREC)

Post-transplant Lymphoproliferative Disease | Transplant-Related Hematologic Malignancy

United Kingdom
Chinese University of Hong Kong

Completed

Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.

Depression | Quality of Life | Anxiety | Hematologic Malignancy

Ethiopia
Acibadem University
Medipol University

Completed

Effects of NMES and Exercise in Hematological Cancer

Muscle Weakness | Hematologic Malignancy

Turkey
Lorenza Scotti

Unknown

Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients (ONCO-AGING)

Solid Tumor | Elderly Patients | Hematologic Malignancies

Italy
Ciusss de L'Est de l'Île de Montréal
ExCellThera inc.; Stem Cell Network

Active, not recruiting

UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

Cord Blood Transplant | High Risk Hematologic Malignancy

Canada
Tarix Pharmaceuticals

Withdrawn

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Hematologic Malignancy | Cord Blood Transplant | Inherited Metabolic Disease

United States
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)

Neoplasm Metastasis
Millennium Pharmaceuticals, Inc.

Completed

Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction

Advanced Solid Tumors | Hematologic Malignancies

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

Pain | Malignant Neoplasm | Dermatologic Complications

United States
Ain Shams University

Completed

Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women (IDA)

Hematologic Pregnancy Complications

Egypt
Assistance Publique - Hôpitaux de Paris

Recruiting

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies (COVIDVAC OH)

Solid Tumor | Thoracic Cancer | Hematologic Malignancy | Cancer, Treatment-Related | Vaccine Response Impaired

France
AstraZeneca

Recruiting

Study of AZD9829 in CD123+ Hematological Malignancies

Hematological Malignancies

United States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

The Study of ICP-248 in Patients With Mature B-cell Malignancies

Hematological Malignancies

China
AstraZeneca

Terminated

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Haematological Malignancies

France, Italy, United States, Korea, Republic of, Germany, Australia
Gamida Cell ltd

Active, not recruiting

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Hematological Malignancies

United States
University of Liege
KU Leuven; Maastricht University Medical Center

Completed

Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

Hematological Malignancies

Belgium, Netherlands
Case Comprehensive Cancer Center

Withdrawn

Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy

Blood Cancer
University Hospital, Toulouse

Completed

Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib (PK-E3I)

Hematological Malignancies

France
Medical University of South Carolina

Terminated

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

Hematological Malignancies

United States
Mitchell Horwitz, MD

Completed

Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant

Hematological Malignancies

United States
St. Jude Children's Research Hospital

Terminated

Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen

Hematological Malignancies

United States
Nantes University Hospital

Completed

Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies (ITT 08-01)

Hematological Malignancies

France
University of Liege
KU Leuven; Amgen; Vrije Universiteit Brussel

Completed

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Hematological Malignancies

Belgium
Hospital Clinic of Barcelona

Unknown

Intrabone Cord Blood Transplantation

Hematological Malignancies

Spain
University of Chicago

Completed

Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

Lymphoma | Leukemia | Myeloma

United States
Center for International Blood and Marrow Transplant...

Completed

Adult Double Cord Blood Transplant Study

Hematologic Malignancies | Cord Blood Stem Cell Transplantation

United States
Northwestern University

Completed

Consumer Knowledge, Attitude, and Behavior Towards Aging Skin

Dermatology

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Hematopoietic and Lymphoid Cell Neoplasm | Non-Neoplastic Hematologic and Lymphocytic Disorder

United States
920th Hospital of Joint Logistics Support Force...
Nanjing Bioheng Biotech Co., Ltd.

Withdrawn

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

B-cell Lymphoma

China
Jean Edward

Completed

Coverage and Cost-of-Care (CC) Links- Financial Navigation Program (CC Links)

Financial Stress | Survivorship | Hematologic Cancer

United States
Wake Forest University Health Sciences

Completed

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

Lymphoma | Leukemia

United States
TCI Co., Ltd.

Recruiting

Evaluation of Human Efficacy of SOD Like Super Drink

Dermatology

Taiwan
Northwestern University

Completed

People of Color and Dermatology: A Deeper Look at Patients' Perceptions of Care and the Need for Greater Diversity in Dermatology

Dermatology

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI); Arcascope, Inc

Completed

Lighting Intervention for Cancer-related Fatigue

Breast Cancer | Fatigue | Prostate Cancer | Hematologic Malignancy | Survivorship

United States
Imperial College Healthcare NHS Trust

Completed

Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT)

Hematologic Malignancy | Graft Versus Host Disease | Allogeneic Stem Cell Transplant | Stem Cell Transplant Complications
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Sepsis | Septic Shock | Hematologic Malignancy | Tumor | Allogeneic Stem Cell Transplantation
University Malaysia Sarawak
University of Malaya

Completed

Single Session of 30-Minute Mindful Breathing in Reducing Fatigue

Fatigue | Hematologic Malignancy

Malaysia
Pavan Reddy, MD

Completed

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

Graft vs Host Disease | Hematologic Malignancies

United States
National Institute of Diabetes and Digestive and...

Completed

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

HIV Infection | Hematologic Neoplasm

United States
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

Hematological Tumors

China
Zhejiang University

Not yet recruiting

Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies

Hematological Malignancies

China
Kangpu Biopharmaceuticals, Ltd.

Recruiting

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

Hematological Malignancies

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

Neoplasms | Hematologic Neoplasms | Healthy Volunteers

United States
Rhizen Pharmaceuticals SA

Completed

Compassionate Use Study of Tenalisib (RP6530)

Hematological Malignancies

United States, Georgia, Poland
medac GmbH

Completed

Dose-range Finding Treosulfan-based Conditioning

Hematological Malignancies

Germany, Finland, Poland, Sweden
Novartis Pharmaceuticals

Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Hematological Malignancies

Germany, Switzerland, France
University of Florida

Completed

UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors

Hematopoietic Neoplasm

United States

Clinical Trials on Dermatologic Conditions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations